Associate Director, Nonclinical Safety EvaluationCity Therapeuticsfull-timeRequired skillsGLPNonclinical SafetyToxicologyStudy DesignRegulatory SubmissionsCRO ManagementAbout City TherapeuticsDeveloping next-generation RNA interference-based medicines for various diseases.This page is fully interactive when JavaScript is enabled. Please enable JavaScript to apply or browse related roles.